百科

4,5-Diphenyl-2-phthalimidomethyl-1,3-oxazole

4,5-Diphenyl-2-phthalimidomethyl-1,3-oxazole

CAS号：328000-89-1

英文名：4,5-Diphenyl-2-phthalimidomethyl-1,3-oxazole

分子式

C24H16N2O3

熔点

密度

分子量

380.395

沸点

溶解度

信号词

危险品标志

若想填写更详细的询价信息，请点击进入询价页面

点我

基本信息

中文名称

4,5-Diphenyl-2-phthalimidomethyl-1,3-oxazole

英文名称

4,5-Diphenyl-2-phthalimidomethyl-1,3-oxazole

中文别名

英文别名

2-(4,5-Diphenyl-oxazol-2-ylmethyl)-isoindole-1,3-dione

CAS号

328000-89-1

分子式

C24H16N2O3

分子量

380.395

精确质量

380.116

PSA

63.41

LOGP

4.7427

下游产品

共找到20个下游商品 >

(R)-2-((4S,5R)-5-Bromomethyl-2,2-dimethyl-[1,3]dioxolan-4-yl)-1-(4,5-diphenyl-oxazol-2-yl)-ethylamine

(R)-2-((4S,5R)-5-Bromomethyl-2,2-dimethyl-[1,3]dioxolan-4-yl)-1-(4,5-diphenyl-oxazol-2-yl)-ethylamine

(1S,2S,5S)-3-(4,5-Diphenyl-1,3-oxazol-2-ylmethylimino)-2,6,6-trimethylbicyclo[3.1.1]heptan-2-ol

(1S,2S,5S)-3-(4,5-Diphenyl-1,3-oxazol-2-ylmethylimino)-2,6,6-trimethylbicyclo[3.1.1]heptan-2-ol

(S)-2-((4S,5R)-5-Bromomethyl-2,2-dimethyl-[1,3]dioxolan-4-yl)-1-(4,5-diphenyl-oxazol-2-yl)-ethylamine

(S)-2-((4S,5R)-5-Bromomethyl-2,2-dimethyl-[1,3]dioxolan-4-yl)-1-(4,5-diphenyl-oxazol-2-yl)-ethylamine

(1S,2S,5S)-3-[(E)-(R)-2-((4S,5R)-5-Bromomethyl-2,2-dimethyl-[1,3]dioxolan-4-yl)-1-(4,5-diphenyl-oxazol-2-yl)-ethylimino]-2,6,6-trimethyl-bicyclo[3.1.1]heptan-2-ol

(1S,2S,5S)-3-[(E)-(R)-2-((4S,5R)-5-Bromomethyl-2,2-dimethyl-[1,3]dioxolan-4-yl)-1-(4,5-diphenyl-oxazol-2-yl)-ethylimino]-2,6,6-trimethyl-bicyclo[3.1.1]heptan-2-ol

(1R,2R,5R)-3-(4,5-Diphenyl-1,3-oxazol-2-ylmethylimino)-2,6,6-trimethylbicyclo[3.1.1]heptan-2-ol

(1R,2R,5R)-3-(4,5-Diphenyl-1,3-oxazol-2-ylmethylimino)-2,6,6-trimethylbicyclo[3.1.1]heptan-2-ol

(1S,2S,5S)-3-[(E)-(R)-Cyclohexyl-(4,5-diphenyl-oxazol-2-yl)-methylimino]-2,6,6-trimethyl-bicyclo[3.1.1]heptan-2-ol

(1S,2S,5S)-3-[(E)-(R)-Cyclohexyl-(4,5-diphenyl-oxazol-2-yl)-methylimino]-2,6,6-trimethyl-bicyclo[3.1.1]heptan-2-ol

下游产品

(R)-2-((4S,5R)-5-Bromomethyl-2,2-dimethyl-[1,3]dioxolan-4-yl)-1-(4,5-diphenyl-oxazol-2-yl)-ethylamine (1S,2S,5S)-3-(4,5-Diphenyl-1,3-oxazol-2-ylmethylimino)-2,6,6-trimethylbicyclo[3.1.1]heptan-2-ol (S)-2-((4S,5R)-5-Bromomethyl-2,2-dimethyl-[1,3]dioxolan-4-yl)-1-(4,5-diphenyl-oxazol-2-yl)-ethylamine (1S,2S,5S)-3-[(E)-(R)-2-((4S,5R)-5-Bromomethyl-2,2-dimethyl-[1,3]dioxolan-4-yl)-1-(4,5-diphenyl-oxazol-2-yl)-ethylimino]-2,6,6-trimethyl-bicyclo[3.1.1]heptan-2-ol (1R,2R,5R)-3-(4,5-Diphenyl-1,3-oxazol-2-ylmethylimino)-2,6,6-trimethylbicyclo[3.1.1]heptan-2-ol (1S,2S,5S)-3-[(E)-(R)-Cyclohexyl-(4,5-diphenyl-oxazol-2-yl)-methylimino]-2,6,6-trimethyl-bicyclo[3.1.1]heptan-2-ol Benzyl (2S,4S,5S)-2-(4,5-diphenyl-1,3-oxazol-2-yl)-4,5-isopropylidenedioxypiperidine-1-carboxylate (1R,2R,5R)-3-[(E)-(S)-2-((4S,5R)-5-Bromomethyl-2,2-dimethyl-[1,3]dioxolan-4-yl)-1-(4,5-diphenyl-oxazol-2-yl)-ethylimino]-2,6,6-trimethyl-bicyclo[3.1.1]heptan-2-ol (1S,2S,5S)-3-[(E)-(R)-1-(4,5-Diphenyl-oxazol-2-yl)-2-methyl-propylimino]-2,6,6-trimethyl-bicyclo[3.1.1]heptan-2-ol (1S,2S,5S)-3-[(E)-(R)-4-Chloro-1-(4,5-diphenyl-oxazol-2-yl)-butylimino]-2,6,6-trimethyl-bicyclo[3.1.1]heptan-2-ol (R)-4-Chloro-1-(4,5-diphenyl-oxazol-2-yl)-butylamine (1S,2S,5S)-3-[(E)-(R)-5-Chloro-1-(4,5-diphenyl-oxazol-2-yl)-pentylimino]-2,6,6-trimethyl-bicyclo[3.1.1]heptan-2-ol (R)-5-Chloro-1-(4,5-diphenyl-oxazol-2-yl)-pentylamine (S)-5-Chloro-1-(4,5-diphenyl-oxazol-2-yl)-pentylamine (1S,2S,5S)-3-[(E)-(R)-1-(4,5-Diphenyl-oxazol-2-yl)-pent-4-enylimino]-2,6,6-trimethyl-bicyclo[3.1.1]heptan-2-ol (2R)-2-(4,5-diphenyloxazol-2-yl)pyrrolidine (1R,2R,5R)-3-[(E)-(S)-1-(4,5-Diphenyl-oxazol-2-yl)-ethylimino]-2,6,6-trimethyl-bicyclo[3.1.1]heptan-2-ol (3aS,6S,7aS)-6-(4,5-Diphenyl-oxazol-2-yl)-2,2-dimethyl-hexahydro-[1,3]dioxolo[4,5-c]pyridine (1S,2S,5S)-3-[(E)-(R)-1-(4,5-Diphenyl-oxazol-2-yl)-ethylimino]-2,6,6-trimethyl-bicyclo[3.1.1]heptan-2-ol (1R,2R,5R)-3-[(E)-(S)-5-Chloro-1-(4,5-diphenyl-oxazol-2-yl)-pentylimino]-2,6,6-trimethyl-bicyclo[3.1.1]heptan-2-ol